A Yale study that includes research and researchers from around the United States has concluded what many a knuckle-dragging deplorable understood for several years. The vaccine was causing long-term, symptoms blamed on the virus.
In this study, we examined symptoms and circulating immune factors and cell typesassociated with chronic illness following COVID-19 vaccination. Post-acute conditions following COVID-19 vaccination have been reported for multiple vaccine platforms including mRNA and adenoviral vectored vaccines . We observed that the general health status of the PVS participants was far below the general US population average based on the GHVAS scores. The patient-reported outcome scores from the PROMIS29 domains were also indicative of lower quality of life. A large fraction of individuals reported the onset of symptoms to be as early as within one day of COVID19 vaccination. Compared with controls, participants with PVS had reduced CD4+ T cell subsets in circulation (both Th1 and Th2) and an increased percentage of TNFα + CD8 T cells. Among cell populations of myeloid origin, cDC2 cells were reduced, and non classical monocytes were elevated among PVS participants. Lower S-specific IgG levels were observed in PVS mainly due to the limited vaccine doses received. Additionally, serological evidence for recent EBV reactivation was also observed. Using machine learning approaches, we further identified a set of 21 core predictive features of PVS status within the LISTEN PVS cohort with potential for further validation and biomarker identification. Most notably, we found elevated levels of spike (S1 and full length S) in circulation up to 709 days after vaccination among a subset with PVS, even in those with no evidence of detectable SARS-CoV-2 infection.
If you skim or read the research paper, you’ll be struck first by the need to suggest that the COVID-19 vaccine saved millions of lives. It’s a rhetorical mandate for anything that might contradict the COVID-era approved narratives, especially if the results produce less-than-flattering conclusions. The Public Health Industrial Complex is reluctant to admit to errors of magnitude, a problem impossible to avoid when the subject matter is the SARS-CoV-2 virus and the institutional response to it. Cats long since out of their bags, waiting for someone in the “respected” scientific community to check them out and then cautiously write a research paper with as many co-authors as possible.
This reminds me that UNH and Dartmouth received a 2.5 million dollar grant in 2023 to study …long COVID. A search for results from any DMC/UNH research produces none, but there are plenty of links to DHMC treatment for long-term COVID-19, post-acute COVID-19 syndrome, appointments, referrals, and news about how to get treated. DMC even has a page about what it is (a question they do not want to answer directly, which does not bode well for their grant/research results).
One link I found references how US Sen. Hassan is concerned about ensuring treatment for Long COVID (in the same vein as Dems concern for mental health or drug abuse issues that are a direct result of left-wing policy). Some people did something, and now there’s this problem, and wow, we need to do something about that. The classic government breaks it so it can grow to a fix-it scheme I talk about so often.
Therefore, the Yale study is a breath of fresh air that slipped through the improperly worn, wholly ineffective cloth mask. It is an opening in the defensive line (while I’m mixing metaphors) and an opportunity for the Hospitals, Pharmaceutical companies, and Health Insurance triad to milk the patients they created with their cure for premiums and treatments they’d have never needed had they not lied to them in the first place.
